Jeffrey D. Chulay

10.8k total citations · 1 hit paper
116 papers, 8.7k citations indexed

About

Jeffrey D. Chulay is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Epidemiology. According to data from OpenAlex, Jeffrey D. Chulay has authored 116 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Public Health, Environmental and Occupational Health, 36 papers in Molecular Biology and 25 papers in Epidemiology. Recurrent topics in Jeffrey D. Chulay's work include Malaria Research and Control (58 papers), Mosquito-borne diseases and control (34 papers) and Virus-based gene therapy research (18 papers). Jeffrey D. Chulay is often cited by papers focused on Malaria Research and Control (58 papers), Mosquito-borne diseases and control (34 papers) and Virus-based gene therapy research (18 papers). Jeffrey D. Chulay collaborates with scholars based in United States, Kenya and Canada. Jeffrey D. Chulay's co-authors include J. David Haynes, Craig J. Canfield, R. E. Desjardins, A.D.M. Bryceson, Christian F. Ockenhouse, David Sixsmith, Harrison C. Spencer, Jeffrey A. Lyon, Terence R. Flotte and Margaret Humphries and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Jeffrey D. Chulay

114 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique

1979 2.2k citations R. E. Desjardins, Craig J. Canfield et al. Antimicrobial Agents and Chemotherapy profile →

Peers

Jeffrey D. Chulay

PHEOH

MB

EPIDE

IMMUN

ID

Toshihiro Horii Japan

Dyann F. Wirth United States

Akhil B. Vaidya United States

James B. Jensen United States

Xin‐zhuan Su United States

Liwang Cui United States

Michael Lanzer Germany

J. David Haynes United States

Steven R. Meshnick United States

Kasturi Haldar United States

Toshihiro Horii Japan

Jeffrey D. Chulay

3.6k ×0.7

PHEOH

3.2k ×1.3

MB

1.1k ×0.7

EPIDE

1.9k ×1.6

IMMUN

928 ×0.8

ID

Citations per year, relative to Jeffrey D. Chulay Jeffrey D. Chulay (= 1×) peers Toshihiro Horii

Countries citing papers authored by Jeffrey D. Chulay

Since Specialization

Citations

This map shows the geographic impact of Jeffrey D. Chulay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey D. Chulay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey D. Chulay more than expected).

Fields of papers citing papers by Jeffrey D. Chulay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey D. Chulay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey D. Chulay. The network helps show where Jeffrey D. Chulay may publish in the future.

Co-authorship network of co-authors of Jeffrey D. Chulay

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey D. Chulay. A scholar is included among the top collaborators of Jeffrey D. Chulay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey D. Chulay. Jeffrey D. Chulay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Song, Chunjuan, Thomas J. Conlon, Wen‐Tao Deng, et al.. (2018). Toxicology and Pharmacology of an AAV Vector Expressing Codon-Optimized RPGR in RPGR-Deficient Rd9 Mice. PubMed. 29(4). 188–197. 16 indexed citations

2.

Komáromy, András M., Caroline J. Zeiss, Roberto Calcedo, et al.. (2017). Safety and Efficacy of AAV5 Vectors Expressing Human or Canine CNGB3 in CNGB3 -Mutant Dogs. PubMed. 28(4). 197–207. 24 indexed citations

3.

Gootwine, E., Ron Ofri, Eyal Banin, et al.. (2017). Safety and Efficacy Evaluation of rAAV2tYF-PR1.7-hCNGA3 Vector Delivered by Subretinal Injection in CNGA3 Mutant Achromatopsia Sheep. PubMed. 28(2). 96–107. 30 indexed citations

4.

Mueller, Christian, Gwladys Gernoux, Alisha M. Gruntman, et al.. (2017). 5 Year Expression and Neutrophil Defect Repair after Gene Therapy in Alpha-1 Antitrypsin Deficiency. Molecular Therapy. 25(6). 1387–1394. 82 indexed citations

5.

Ye, Guo-jie, Ewa Budzynski, T. Michael Nork, et al.. (2016). Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia. 1 indexed citations

6.

Ye, Guo-jie, Ewa Budzynski, T. Michael Nork, et al.. (2016). Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia. PubMed. 27(1). 27–36. 20 indexed citations

7.

Ye, Guo-jie, Ewa Budzynski, T. Michael Nork, et al.. (2016). Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia. PubMed. 27(1). 37–48. 53 indexed citations

8.

Ye, Guojie, Ewa Budzynski, P. Elliott Miller, et al.. (2015). Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin. PubMed. 26(3). 165–176. 46 indexed citations

9.

Ye, Guojie, Thomas J. Conlon, Kirsten Erger, et al.. (2015). Safety and Biodistribution Evaluation of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin, in RS1-Deficient Mice. PubMed. 26(3). 177–184. 20 indexed citations

10.

Ye, Guo-jie, Marina M. Scotti, Darby L. Thomas, et al.. (2014). Herpes Simplex Virus Clearance During Purification of a Recombinant Adeno-Associated Virus Serotype 1 Vector. PubMed. 25(4). 212–217. 16 indexed citations

11.

Ye, Guo-jie, Ewa Budzynski, Nader Sheibani, et al.. (2014). Development and Evaluation of Cone-Specific Promoters in Non-human Primates for Gene Therapy of Congenital Cone Diseases Including Achromatopsia. Investigative Ophthalmology & Visual Science. 55(13). 837–837.

12.

Chulay, Jeffrey D., Darby L. Thomas, David R. Knop, et al.. (2010). Preclinical Evaluation of a Recombinant Adeno-Associated Virus Vector Expressing Human Alpha-1 Antitrypsin Made Using a Recombinant Herpes Simplex Virus Production Method. Human Gene Therapy. 22(2). 155–165. 48 indexed citations

13.

Baird, J. Kevin, David J. Fryauff, Priyanto Sismadi, et al.. (2002). Randomized, Placebo‐Controlled Trial of Atovaquone/Proguanil for the Prevention ofPlasmodium falciparumorPlasmodium vivaxMalaria among Migrants to Papua, Indonesia. Clinical Infectious Diseases. 35(7). 825–833. 54 indexed citations

14.

Høgh, Birthe, P D Clarke, Daniel Camus, et al.. (2000). Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. The Lancet. 356(9245). 1888–1894. 103 indexed citations

15.

Chulay, Jeffrey D.. (1998). Challenges in the development of antimalarial drugs with causal prophylactic activity. Transactions of the Royal Society of Tropical Medicine and Hygiene. 92(6). 577–579. 14 indexed citations

16.

Waag, David M., Jeffrey D. Chulay, Thomas J. Marrie, Marilyn J. England, & J C Williams. (1995). Validation of an enzyme immunoassay for serodiagnosis of acute Q fever. European Journal of Clinical Microbiology & Infectious Diseases. 14(5). 421–427. 31 indexed citations

17.

Chulay, Jeffrey D., et al.. (1990). Host Receptors for Malaria-Infected Erythrocytes. American Journal of Tropical Medicine and Hygiene. 43(2_Part_2). 6–14. 20 indexed citations

18.

Orlandi, Palmer A., B. Kim Lee Sim, Jeffrey D. Chulay, & J. David Haynes. (1990). Characterization of the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum. Molecular and Biochemical Parasitology. 40(2). 285–294. 71 indexed citations

19.

Lyon, Jeffrey A., Alan W. Thomas, Ted Hall, & Jeffrey D. Chulay. (1989). Specificities of antibodies that inhibit merozoite dispersal from malaria-infected erythrocytes. Molecular and Biochemical Parasitology. 36(1). 77–85. 49 indexed citations

20.

Desjardins, R. E., Craig J. Canfield, J. David Haynes, & Jeffrey D. Chulay. (1979). Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrobial Agents and Chemotherapy. 16(6). 710–718. 2207 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact